AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27879582 — intervention group
Group type: COMPARATOR
Intervention: Saline expanders
Number of subjects: 150
Study 24336012 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily
Number of subjects: 41
Study 24336012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 22397392 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dairy intake
Number of subjects: 554
Study 22397392 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 554
Study 22397392 — intervention group
Group type: EXPERIMENTAL
Intervention: Soured milk products
Number of subjects: 554
Study 22397392 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoghurt
Number of subjects: 554
Study 22397392 — intervention group
Group type: COMPARATOR
Intervention: Cheese
Number of subjects: 554
Study 22397392 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose
Number of subjects: 554
Study 22397392 — intervention group
Group type: COMPARATOR
Intervention: Calcium
Number of subjects: 554
Study 20147814 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CTX test performed preoperatively in 54 patients taking oral bisphosphonates (BPs)
Number of subjects: 163
Study 20147814 — intervention group
Group type: COMPARATOR
Intervention: No CTX test performed in 109 patients taking oral BPs (control group)
Number of subjects: 163
Study 18214726 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 998
Study 18214726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 998
Study 15669886 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine CR (25-75 mg/day)
Number of subjects: 889
Study 15669886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 889
Study 12963899 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 37
Study 12963899 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin cream 0.025%
Number of subjects: 37
Study 12963899 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin microsphere gel 0.1%
Number of subjects: 37
Study 12963899 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of adapalene gel 0.1% with various antimicrobial agents
Number of subjects: 37
Study 11401938 — intervention group
Group type: EXPERIMENTAL
Intervention: Thin-strut stent (strut thickness of 50 microm)
Number of subjects: 651
Study 11401938 — intervention group
Group type: COMPARATOR
Intervention: Thick-strut stent (strut thickness of 140 microm)
Number of subjects: 651
Study 11401938 — intervention group
Group type: EXPERIMENTAL
Intervention: Both stent types
Number of subjects: 651
Study 9234040 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 18
Study 9234040 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hr patch
Number of subjects: 18
Study 9234040 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-hr patch
Number of subjects: 18
Study 9234040 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hr patch plus gum
Number of subjects: 18
Study 9234040 — intervention group
Group type: EXPERIMENTAL
Intervention: Double 24-hr patch
Number of subjects: 18
Study 9234040 — intervention group
Group type: COMPARATOR
Intervention: No nicotine replacement
Number of subjects: 18
Study 7961259 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory flow-resistive loading (L2: 125 cmH2O.l‐1.s)
Number of subjects: 10
Study 7961259 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory flow-resistive loading (L3: 250 cmH2O.l‐1.s)
Number of subjects: 10
Study 3475725 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-amniotic 1.5 mg 15(S) 15 methyl PGF2 alpha (PGF2 alpha)
Number of subjects: 20
Study 3475725 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin 25 mg and 50 mg orally three and one hour before PGF2 alpha
Number of subjects: 20
Study 2076744 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal suspension (5 g as 200 ml)
Number of subjects: 8
Study 2076744 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal tablets (40 of 125 mg)
Number of subjects: 8
Study 2076744 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal capsules (25 of 200 mg)
Number of subjects: 8
Study 2076744 — intervention group
Group type: COMPARATOR
Intervention: Control treatment (suspension medium without AC)
Number of subjects: 8
Study 1215547 — intervention group
Group type: EXPERIMENTAL
Intervention: 15(S)15‐methyl‐PGF2alpha (400 mug extra‐amniotically one hour prior to vacuum aspiration)
Number of subjects: 39
Study 1215547 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg X 4 over 24 hours)
Number of subjects: 39
Study 1215547 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg X 6 over 36 hours)
Number of subjects: 39
Study 1215547 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 women)
Number of subjects: 39
Study 31107276 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintained PEEP (n = 16)
Number of subjects: 30
Study 31107276 — intervention group
Group type: COMPARATOR
Intervention: Zero PEEP (n = 14)
Number of subjects: 30
Study 31107276 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 27899531 — intervention group
Group type: EXPERIMENTAL
Intervention: RT disease management program
Number of subjects: 428
Study 27899531 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 428
Study 26978624 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced techniques including minimally invasive surgical sanitation of infected fracture zone followed by differentiated tactics of consistent and gradual minimally invasive functionally stable osteosynthesis with modern APS and implants on a background of conservative therapy consisting of Cycloferon.
Number of subjects: 60
Study 26978624 — intervention group
Group type: COMPARATOR
Intervention: Traditional scheme using only external fixation devices or metal obsolete models.
Number of subjects: 60
Study 23888318 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (2 g/day)
Number of subjects: 98
Study 23888318 — intervention group
Group type: EXPERIMENTAL
Intervention: High-oleic sunflower oil (8 g/day)
Number of subjects: 98
Study 23888318 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (2 g/day) and High-oleic sunflower oil (8 g/day)
Number of subjects: 98
Study 21349225 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg/day)
Number of subjects: 70
Study 21349225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 19216890 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 42
Study 19216890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 17383095 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical nerve stimulation (ENS)
Number of subjects: 1227
Study 17383095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1227
Study 15536111 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA 50 mg/d for 6 months
Number of subjects: 56
Study 15536111 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 11238151 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.97 mg/kg amphotericin B by continuous infusion over 24 hours
Number of subjects: 80
Study 11238151 — intervention group
Group type: COMPARATOR
Intervention: 0.95 mg/kg amphotericin B by rapid infusion over four hours
Number of subjects: 80
Study 9768384 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program based on Bandura's self-efficacy theory and Freire's empowerment pedagogy
Number of subjects: 88
Study 7837144 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA)
Number of subjects: 91
Study 7837144 — intervention group
Group type: COMPARATOR
Intervention: Systemic lupus erythematosus (SLE)
Number of subjects: 91
Study 7837144 — intervention group
Group type: COMPARATOR
Intervention: Cancer
Number of subjects: 91
Study 7837144 — intervention group
Group type: COMPARATOR
Intervention: Pneumonia
Number of subjects: 91
Study 7837144 — intervention group
Group type: COMPARATOR
Intervention: Congestive heart failure
Number of subjects: 91
Study 7837144 — intervention group
Group type: COMPARATOR
Intervention: Tuberculous pleurisy
Number of subjects: 91
Study 3417935 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day video-based workshop for teaching the conversational model of psychotherapy
Number of subjects: 0
Study 3417935 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 30543461 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg thrice daily for 14 days)
Number of subjects: 83
Study 27484978 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise plus pharmacotherapy
Number of subjects: 26
Study 27484978 — intervention group
Group type: COMPARATOR
Intervention: Only pharmacotherapy
Number of subjects: 26
Study 26033708 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy with paclitaxel plus gemcitabine (PG)
Number of subjects: 0
Study 26033708 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study 23587015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 200
Study 23587015 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with sertraline
Number of subjects: 200
Study 22007522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril/hydrochlorothiazide combined tablets (high, medium, low doses)
Number of subjects: 0
Study 22007522 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated administration of lisinopril/hydrochlorothiazide combined tablets
Number of subjects: 0
Study 22007522 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (test medication)
Number of subjects: 0
Study 22007522 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (test medication)
Number of subjects: 0
Study 18446103 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric feeding (n = 27)
Number of subjects: 44
Study 18446103 — intervention group
Group type: COMPARATOR
Intervention: Postpyloric feeding (n = 17)
Number of subjects: 44
Study 16483884 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional oil (Phytosterols mixed with medium-chain triglycerides and high-oleic canola oil)
Number of subjects: 23
Study 16483884 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (Control)
Number of subjects: 23
Study 14739723 — intervention group
Group type: EXPERIMENTAL
Intervention: Unipolar and bipolar electrograms (61 PVs)
Number of subjects: 44
Study 14739723 — intervention group
Group type: COMPARATOR
Intervention: Bipolar electrograms only (53 PVs)
Number of subjects: 44
Study 10885423 — intervention group
Group type: EXPERIMENTAL
Intervention: Diesel exhaust (DE) exposure (300 microg x m(‐3) for 1 h)
Number of subjects: 15
Study 10885423 — intervention group
Group type: COMPARATOR
Intervention: Sputum induction procedure
Number of subjects: 15
Study 8620790 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine 20 mg
Number of subjects: 20
Study 1622645 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy only
Number of subjects: 719
Study 1622645 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy and adjuvant tamoxifen for one year
Number of subjects: 719
Study 1622645 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen without radiotherapy
Number of subjects: 719
Study 6381432 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromodeoxyuridine (BUdR) with conventional fractionated radiation
Number of subjects: 0
Study 6381432 — intervention group
Group type: EXPERIMENTAL
Intervention: Iododeoxyuridine (IUdR) with conventional fractionated radiation
Number of subjects: 0
Study 6381432 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusions of BUdR and IUdR
Number of subjects: 0
Study 30054160 — intervention group
Group type: EXPERIMENTAL
Intervention: 11vPHiD-CV
Number of subjects: 951
Study 30054160 — intervention group
Group type: EXPERIMENTAL
Intervention: 12vPHiD-CV
Number of subjects: 951
Study 30054160 — intervention group
Group type: COMPARATOR
Intervention: PHiD-CV
Number of subjects: 951
Study 30054160 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 951
Study 29695500 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored rituximab regimen (500 mg infusion at randomisation, reinfusion based on CD19+B lymphocytes or ANCA levels)
Number of subjects: 162
Study 29695500 — intervention group
Group type: COMPARATOR
Intervention: Fixed-schedule rituximab regimen (500 mg infusion on days 0 and 14, then at 6, 12, and 18 months)
Number of subjects: 162
Study 29471771 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week self-management program
Number of subjects: 46
Study 29471771 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (pamphlets on exercise and joint care)
Number of subjects: 46
Study 24118023 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg day(-1) for 4 weeks
Number of subjects: 60
Study 24118023 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg day(-1) for 4 weeks
Number of subjects: 60
Study 24118023 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg day(-1) for 4 weeks
Number of subjects: 60
Study 24118023 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group (no treatment)
Number of subjects: 60
Study 22928363 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-caloric diet (1200‐1500 kcal/day) with modified fatty acids pool (PUFA n‐3/n‐6 ratio 1:5)
Number of subjects: 23
Study 22928363 — intervention group
Group type: COMPARATOR
Intervention: Control group (PUFA n‐3/n‐6 ratio 1:10)
Number of subjects: 23
Study 20521025 — intervention group
Group type: EXPERIMENTAL
Intervention: SIGH (periodical high pressure breaths)
Number of subjects: 21
Study 20521025 — intervention group
Group type: EXPERIMENTAL
Intervention: BIPAP (biphasic positive pressure ventilation)
Number of subjects: 21
Study 20521025 — intervention group
Group type: COMPARATOR
Intervention: CPAP(basal)
Number of subjects: 21
Study 20521025 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP(final)
Number of subjects: 21
Study 18521686 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreduction followed by hyperthermic intraperitoneal chemotherapy (HIPEC) and systemic chemotherapy
Number of subjects: 10
Study 18521686 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy alone (Control)
Number of subjects: 10
Study 15955035 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with cluster headache (CH)
Number of subjects: 37
Study 15955035 — intervention group
Group type: COMPARATOR
Intervention: Control group (individuals without CH)
Number of subjects: 37
Study 15955035 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CH
Number of subjects: 37
Study 15955035 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CH with BMI > 25 kg/m(2)
Number of subjects: 37
Study 15955035 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CH > 40 years old
Number of subjects: 37
Study 15955035 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with CH with BMI < 25 kg/m(2) and < 40 years old
Number of subjects: 37
Study 12460092 — intervention group
Group type: COMPARATOR
Intervention: Usual ED evaluation strategy (n = 1260)
Number of subjects: 2475
Study 12460092 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual strategy supplemented with acute resting myocardial perfusion imaging (n = 1215)
Number of subjects: 2475
Study 10048613 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (300 IU/kg three times a week s.c.) and oral iron (ferrofumarate, 6 mg of iron/kg per day)
Number of subjects: 41
Study 10048613 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO (300 IU/kg three times a week s.c.) and intramuscular iron (ferroxypolymaltose, once 12 mg of iron/kg weekly)
Number of subjects: 41
Study 10048613 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular iron (ferroxypolymaltose, once 12 mg of iron/kg weekly) without rHuEPO
Number of subjects: 41
Study 7745510 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic surfactant
Number of subjects: 1540
Study 7745510 — intervention group
Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 1540
Study 2105191 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse flow oxygen
Number of subjects: 100
Study 2105191 — intervention group
Group type: COMPARATOR
Intervention: Continuous flow oxygen
Number of subjects: 100
Study 2105191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost savings from pulse flow oxygen
Number of subjects: 100
Study 375461 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine methonitrate 2 mg
Number of subjects: 18
Study 375461 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 200 microgram
Number of subjects: 18
Study 375461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of salbutamol and atropine methonitrate
Number of subjects: 18
Study 375461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31937341 — intervention group
Group type: COMPARATOR
Intervention: Bayesian adaptive designs with response adaptive randomisation (RAR)
Number of subjects: 0
Study 31937341 — intervention group
Group type: COMPARATOR
Intervention: Bayesian adaptive designs with arm dropping
Number of subjects: 0
Study 31937341 — intervention group
Group type: COMPARATOR
Intervention: Original trial designs
Number of subjects: 0
Study 30651032 — intervention group
Group type: EXPERIMENTAL
Intervention: NT-proBNP
Number of subjects: 5275
Study 30651032 — intervention group
Group type: EXPERIMENTAL
Intervention: hs cardiac troponin I
Number of subjects: 5275
Study 30651032 — intervention group
Group type: EXPERIMENTAL
Intervention: hs troponin T
Number of subjects: 5275
Study 30651032 — intervention group
Group type: EXPERIMENTAL
Intervention: growth differentiation factor-15
Number of subjects: 5275
Study 27354046 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous procainamide (10 mg/kg/20 min)
Number of subjects: 74
Study 27354046 — intervention group
Group type: COMPARATOR
Intervention: Intravenous amiodarone (5 mg/kg/20 min)
Number of subjects: 74
Study 27354046 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous procainamide (10 mg/kg/20 min) in patients with structural heart disease
Number of subjects: 74
Study 27354046 — intervention group
Group type: COMPARATOR
Intervention: Intravenous amiodarone (5 mg/kg/20 min) in patients with structural heart disease
Number of subjects: 74
Study 26248345 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser group (40 eyes)
Number of subjects: 80
Study 26248345 — intervention group
Group type: COMPARATOR
Intervention: Manual group (40 eyes)
Number of subjects: 80
Study 23758461 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable Mandibular Retractor (RMR)
Number of subjects: 33
Study 23758461 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 33
Study 21371499 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=149)
Number of subjects: 297
Study 21371499 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=148)
Number of subjects: 297
Study 18356618 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based quadriceps exercise
Number of subjects: 121
Study 18356618 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroidal antiinflammatory drugs (NSAIDs)
Number of subjects: 121
Study 17056973 — intervention group
Group type: EXPERIMENTAL
Intervention: D-NS (nerve stimulator guidance)
Number of subjects: 135
Study 17056973 — intervention group
Group type: EXPERIMENTAL
Intervention: P-NS (proximal block site with nerve stimulator guidance)
Number of subjects: 135
Study 17056973 — intervention group
Group type: COMPARATOR
Intervention: D (distal block site without nerve stimulator guidance)
Number of subjects: 135
Study 17056973 — intervention group
Group type: EXPERIMENTAL
Intervention: D-NS
Number of subjects: 135
Study 17056973 — intervention group
Group type: COMPARATOR
Intervention: D
Number of subjects: 135
Study 17056973 — intervention group
Group type: EXPERIMENTAL
Intervention: P-NS
Number of subjects: 135
Study 12881816 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke Impact Scale (SIS) version 3.0
Number of subjects: 696
Study 10933082 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard insecticide aerosol A
Number of subjects: 25
Study 10933082 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard insecticide aerosol B
Number of subjects: 25
Study 10933082 — intervention group
Group type: EXPERIMENTAL
Intervention: Low irritant insecticide aerosol C
Number of subjects: 25
Study 10933082 — intervention group
Group type: COMPARATOR
Intervention: Negative control aerosol
Number of subjects: 25
Study 1600935 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloreen supplementation
Number of subjects: 64
Study 1600935 — intervention group
Group type: COMPARATOR
Intervention: Starch (control)
Number of subjects: 64
Study 2578352 — intervention group
Group type: EXPERIMENTAL
Intervention: Running under hot conditions (rectal temperature increase averaging 2.3 degrees C)
Number of subjects: 6
Study 2578352 — intervention group
Group type: COMPARATOR
Intervention: Running with additional cooling (rectal temperature rise reduced to an average of 1.0 degree C)
Number of subjects: 6
Study 30874389 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopic assisted reduction and percutaneous intramedullary nail fixation (trial group)
Number of subjects: 22
Study 30874389 — intervention group
Group type: COMPARATOR
Intervention: Traditional manual reduction and percutaneous intramedullary nail fixation (control group)
Number of subjects: 22
Study 28404231 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Autobiographical Memory retrieval
Number of subjects: 12
Study 28404231 — intervention group
Group type: COMPARATOR
Intervention: Neutral Autobiographical Memory retrieval
Number of subjects: 12
Study 27595698 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding with ZDV prophylaxis for 6 months
Number of subjects: 1200
Study 27595698 — intervention group
Group type: COMPARATOR
Intervention: Formula feeding with 4 weeks of ZDV
Number of subjects: 1200
Study 24142460 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexchlorpheniramine 4 mg
Number of subjects: 12
Study 24142460 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 1 mg
Number of subjects: 12
Study 24142460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12